⌘K

16:10:19·42m

SECFilingvia Quantisnow

SEC Form 424B3 filed by BioRestorative Therapies Inc.

ByQuantisnow·Wall Street's wire, on your screen.

BRTX· BioRestorative Therapies Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

BRTX
BioRestorative Therapies Inc.
Health Care

Recent analyst ratings

Dec 1UpdateRoth Capital$37.00

Related

PR6h
BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform
SEC1d
SEC Form EFFECT filed by BioRestorative Therapies Inc.
SEC3d
SEC Form POS AM filed by BioRestorative Therapies Inc.
SEC6d
BioRestorative Therapies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
PR9d
BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform
SEC9d
SEC Form POS AM filed by BioRestorative Therapies Inc.
SEC16d
SEC Form DEF 14A filed by BioRestorative Therapies Inc.
PR23d
BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform